Fig. 6From: Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myelomaROC analysis of the sensitivity and specificity for survival prediction by lncRNA-based risk model and 17-gene prognostic model. The time-dependent ROC curve was used to evaluate the prognostic performance for survival prediction. Performance comparison was assessed between four-lncRNA signature and 17-gene signature by calculating the area under the ROC curves (AUC) in three datasetsBack to article page